AB vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

AB

45.9
AI Score
VS
FHI Wins

FHI

61.6
AI Score

Investment Advisor Scores

AB

46score
Recommendation
HOLD

FHI

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AB FHI Winner
Net Income 403.30M 156.96M FHI
ROA 18.1% 12.6% FHI
Total Assets 2.23B 1.25B FHI

Relative Price Performance (Last 90 Days)

AB 1M: -4.4% · 3M: -5.0% FHI 1M: -7.7% · 3M: -3.2%

Current Technical Phase

AB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 38

RSI (14): 37.9 · Price: $35.00

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.1 · Price: $56.07

Fundamentals Snapshot

Metric AB FHI
Market Cap — —
Forward P/E 9.3 9.5
Trailing P/E 10.4 10.4
Revenue (TTM) — —
Revenue Growth -0.4% 0.2%
Gross Margin 1.0% 0.7%
Operating Margin 1.0% 0.3%
EPS 3.36 5.38
Dividend Yield 0.10% 0.02%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.